The author discloses the following relationships: Consulting (Abbvie, Regeneron, Johnson & Johnson, Novartis, Smart Immune, Bristol Myers Squibb, Gracell); DSMB service (Johnson & Johnson); research funding (Johnson & Johnson, Novartis, CRISPR Therapeutics).